
Yeslife Pharmaceuticals Limited
About Yeslife Pharmaceuticals Limited
Data last updated:
Yeslife Pharmaceuticals Limited is a public limited company based in New Delhi, Delhi, India. It operates in the animal health services segment of the veterinary services sector. It was incorporated on 17 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85200DL2020PLC373282. Its GSTIN is 07AABCY3177E1ZB (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3.75 Lakh. It is led by directors including Muhammad Musafir Ansari (Managing Director) and Shahnaz Perween (Whole-Time Director).
Its last annual general meeting (AGM) was held on 28 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Shop No. 711 Westend Mall Main Nazafgarh Road, Janakpuri, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2022, the company reported a revenue of ₹4.37 Lakh, a growth of 119% compared to the previous year. For the same year it recorded a net loss of ₹2.53 Lakh (net margin -58.1%) and EBITDA of -₹2.53 Lakh (EBITDA margin -58.1%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Yeslife Pharmaceuticals Limited's registered office is in New Delhi, Delhi.
- Registered AddressShop No. 711 Westend Mall Main Nazafgarh Road, Janakpuri, New Delhi, Delhi, India – 110058
- IndustryVeterinary, Animal Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Yeslife Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Yeslife Pharmaceuticals Limited, buy the company report.
Financials of Yeslife Pharmaceuticals Limited
FY 2022 filings availableYeslife Pharmaceuticals Limited reported revenue of ₹4.37 Lakh (up 119% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue rose 119% in the latest year. EBITDA fell 854% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹2.53 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹2.53 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -58.1% | |
| Net Profit Margin | -58.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Yeslife Pharmaceuticals Limited, buy the company report.
Board of directors of Yeslife Pharmaceuticals Limited
Yeslife Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mithilesh Kumar Yadav | Director | 06 Dec 2024 | 1 Years 11 Months | Current |
| Muhammad Musafir Ansari Also directs: Yeslife Business Experts LLP, Yeslife Agrotech Private Limited, Nazaayat Foundation and 1 more | Managing Director | 17 Nov 2020 | 5 Years 11 Months | Current |
| Shahnaz Perween | Whole-Time Director | 17 Nov 2020 | 5 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Yeslife Pharmaceuticals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Yeslife Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Yeslife Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCY3177E1ZB | Delhi | Active | 23 Dec 2020 |
To see the full GST registrations and return filing status of Yeslife Pharmaceuticals Limited, buy the company report.
Recent activity
Yeslife Pharmaceuticals Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Jaswinder Singh ceased to be Director on 06 Dec 2024.
Frequently asked questions
Yeslife Pharmaceuticals is an active public limited company based in New Delhi, Delhi, India. The company works in animal health services, within the veterinary industry. It was incorporated on 17 November 2020 (6+ years old) and is registered under CIN U85200DL2020PLC373282.
Yeslife Pharmaceuticals has 3 current directors:
- Muhammad Musafir Ansari - Managing Director
- Shahnaz Perween - Whole-Time Director
- Mithilesh Kumar Yadav - Director
The latest financial statements of Yeslife Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 28 September 2022. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Yeslife Pharmaceuticals is 07AABCY3177E1ZB, registered in Delhi.
The CIN (Corporate Identification Number) of Yeslife Pharmaceuticals is U85200DL2020PLC373282. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yeslife Pharmaceuticals was incorporated on 17 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Jaswinder Singh ceased to be Director on 06 Dec 2024. Mithilesh Kumar Yadav was appointed as Director on 06 Dec 2024. Muhammad Musafir Ansari was appointed as Managing Director on 17 Nov 2020. Yeslife Pharmaceuticals has 4 board changes on record in total.
The registered office of Yeslife Pharmaceuticals is at Shop No. 711 Westend Mall Main Nazafgarh Road, Janakpuri, New Delhi, Delhi, India – 110058.
Yeslife Pharmaceuticals operates in the veterinary industry, in the animal health services segment.
The compliance status of Yeslife Pharmaceuticals is compliant as of 26 July 2026. The company is actively filing with the Registrar of Companies.

